Stock Rating Report for FURX
|
|
Stock Information
| Ticker |
FURX |
| Company Name |
Furiex Pharmaceuticals, Inc |
| Current Price |
$16.70 |
| Previous Close |
$15.76 |
| Industry |
Business Services |
| Sector |
CONSUMER DISCRETIONARY |
| Long Stop Loss |
Members Only |
| Short Stop Loss |
Members Only |
| Expected Move |
Members Only |
| Optionable? |
Yes
|
StockProphet Ratings
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
Sector Risks
Chart
We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for FURX. However, we only show it to our subscribers.
We update our ratings and stop losses EVERY WEEK.
Don't miss out on what we recommend for Furiex Pharmaceuticals, Inc next week. Sign up today and start making money!
Demand Fundamentals
|
Demand Technicals
Company Profile
Furiex Pharmaceuticals, Inc., a drug development collaboration company, engages in the compound partnering business in the United States and Europe. It collaborates with pharmaceutical and biotechnology companies to increase the value of their early stage drug candidates. The company has rights for compounds in various stages of development and commercialization, including rights to royalties and sales-based milestones from the collaboration with ALZA Corporation on Prilig for premature ejaculation- from Takeda Pharmaceutical Company Limited on alogliptin and alogliptin-containing products- and licenses from Janssen Pharmaceutica, N.V. for fluoroquinolone antibiotic compound for the treatment of skin and skin structure infections, such as abscesses that occur deep in the skin layers and respiratory infections, and for a compound that is a mu opioid receptor agonist and delta opioid receptor antagonist. Its collaborations also comprise license from Ranbaxy Laboratories, Ltd. for statin compound for the treatment of dyslipidemia- and for various therapeutic candidates developed by Eli Lilly and Company. The company was founded in 1998 and is headquartered in Morrisville, North Carolina. Furiex Pharmaceuticals, Inc. (NasdaqGM:FURX) operates independently of Pharmaceutical Product Development Inc. as of June 15, 2010.
|
Latest News
| Tue, 15 May 2012 22:04:10 GMT | Healthcare Business Recap: Johnson & Johnson Drops This Premature Ejaculation Drug | | Tue, 15 May 2012 21:43:31 GMT | Einhorn Reveals Xerox and Expedia Stakes | | Tue, 15 May 2012 13:04:27 GMT | Stocks to Watch: Groupon, Avon Products, Agilent Technologies | | Tue, 15 May 2012 11:07:11 GMT | FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial | | Mon, 14 May 2012 22:26:17 GMT | UPDATE 1-Furiex says J&J returns sexual dysfunction drug rights | | Mon, 14 May 2012 21:33:00 GMT | Furiex Pharmaceuticals and Menarini Announce License Agreement for Priligy® | | Mon, 14 May 2012 21:30:00 GMT | Furiex Pharmaceuticals Announces Agreement to Transfer Priligy® Product Rights | | Sat, 12 May 2012 17:04:28 GMT | FURIEX PHARMACEUTICALS, INC. Financials | | Mon, 07 May 2012 20:20:42 GMT | FURIEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report | | Thu, 03 May 2012 20:49:47 GMT | FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements | | Thu, 03 May 2012 20:05:00 GMT | Furiex Reports First Quarter 2012 Financial Results | | Tue, 01 May 2012 09:00:00 GMT | Furiex Pharmaceuticals Inc. Stock Downgraded (FURX) | | Thu, 26 Apr 2012 10:42:00 GMT | Furiex Confirms Takeda?s Receipt of Complete Response Letter from the FDA for Alogliptin and Fixed-Dose Combination Alogliptin and Pioglitazone | | Tue, 17 Apr 2012 17:33:00 GMT | Is Furiex Due For A Bounce? | | Fri, 13 Apr 2012 23:16:00 GMT | 3 Outperforming Small Caps Bought Up By Insiders And Hedge Funds | | Tue, 03 Apr 2012 20:05:00 GMT | Furiex Pharmaceuticals Announces First Quarter 2012 Earnings Release and Conference Call | | Mon, 02 Apr 2012 09:49:30 GMT | 9 Healthcare Stocks With Major Catalysts Due in April | | Fri, 30 Mar 2012 16:14:55 GMT | Insiders Bought Shares in These Top Companies in Late March | | Thu, 29 Mar 2012 12:40:48 GMT | Bio Tech Stocks With Huge Upside Or Downside Potential In April | | Mon, 26 Mar 2012 13:04:11 GMT | Furiex Pharmaceutical's Coming Events Could Boost Stock Price | News provided by Yahoo! Finance |
|
|
|
|
